Affected Systems |
|
|
|
|
|
|
|
|
craniofacial
|
|
√
|
|
|
√
|
√
|
|
abnormal tooth development
|
|
√
|
|
|
√
|
|
|
delayed tooth eruption
|
|
|
|
|
|
√
|
|
failure of tooth eruption
|
|
|
|
|
|
√
|
|
endocrine/exocrine glands
|
|
√
|
|
|
|
|
|
increased fibroadenoma incidence
|
|
√
|
|
|
|
|
|
growth/size/body
|
|
√
|
|
|
√
|
√
|
|
abnormal tooth development
|
|
√
|
|
|
√
|
|
|
delayed tooth eruption
|
|
|
|
|
|
√
|
|
failure of tooth eruption
|
|
|
|
|
|
√
|
|
decreased body size
|
|
|
|
|
|
√
|
|
decreased body weight
|
|
|
|
|
|
√
|
|
hearing/vestibular/ear
|
|
|
|
|
|
√
|
|
increased susceptibility to otitis media
|
|
|
|
|
|
√
|
|
immune system
|
|
|
|
|
|
√
|
|
increased susceptibility to otitis media
|
|
|
|
|
|
√
|
|
integument
|
|
√
|
|
|
|
|
|
increased fibroadenoma incidence
|
|
√
|
|
|
|
|
|
mortality/aging
|
√
|
|
√
|
√
|
√
|
√
|
√
|
decreased survivor rate
|
|
|
√
|
√
|
√
|
√
|
|
premature death
|
|
|
|
|
|
√
|
|
postnatal lethality, complete penetrance
|
|
|
|
|
|
|
√
|
embryonic lethality, complete penetrance
|
√
|
|
|
|
|
|
|
neoplasm
|
|
√
|
|
|
√
|
|
√
|
neoplasm
|
|
N
|
|
|
|
|
|
increased fibroadenoma incidence
|
|
√
|
|
|
|
|
|
osseous metaplasia
|
|
√
|
|
|
√
|
|
|
increased neurofibroma incidence
|
|
√
|
|
|
|
|
|
increased hamartoma incidence
|
|
|
|
|
|
|
√
|
increased lung adenocarcinoma incidence
|
|
√
|
|
|
|
|
|
increased renal carcinoma incidence
|
|
√
|
|
|
|
|
|
increased sarcoma incidence
|
|
√
|
|
|
|
|
|
increased neurofibrosarcoma incidence
|
|
√
|
|
|
√
|
|
|
increased osteosarcoma incidence
|
|
√
|
|
|
|
|
|
increased mesothelioma incidence
|
|
√
|
|
|
√
|
|
|
increased odontoma incidence
|
|
|
|
|
√
|
|
|
increased odontosarcoma incidence
|
|
|
|
|
√
|
|
|
increased Schwannoma incidence
|
|
|
|
|
√
|
|
|
increased osteoma incidence
|
|
√
|
|
|
|
|
|
nervous system
|
|
√
|
|
|
√
|
|
√
|
nervous system phenotype
|
|
N
|
|
|
|
|
|
increased neurofibroma incidence
|
|
√
|
|
|
|
|
|
increased neurofibrosarcoma incidence
|
|
√
|
|
|
√
|
|
|
increased Schwannoma incidence
|
|
|
|
|
√
|
|
|
abnormal Schwann cell morphology
|
|
|
|
|
√
|
|
√
|
renal/urinary system
|
|
√
|
|
|
√
|
|
|
increased renal carcinoma incidence
|
|
√
|
|
|
|
|
|
abnormal renal tubule morphology
|
|
√
|
|
|
√
|
|
|
respiratory system
|
|
√
|
|
|
|
|
|
increased lung adenocarcinoma incidence
|
|
√
|
|
|
|
|
|
skeleton
|
|
√
|
|
|
√
|
√
|
|
abnormal tooth development
|
|
√
|
|
|
√
|
|
|
delayed tooth eruption
|
|
|
|
|
|
√
|
|
failure of tooth eruption
|
|
|
|
|
|
√
|
|
increased osteosarcoma incidence
|
|
√
|
|
|
|
|
|
increased osteoma incidence
|
|
√
|
|
|
|
|
|
abnormal osteoblast morphology
|
|
√
|
|
|
√
|
|
|